Bicycle Therapeutics Announces Updated Preclinical Data on SARS-CoV-2 Antivirals at the 2022 Microbiology Society Annual Meeting April 8, 2022
Werewolf Therapeutics and Jazz Pharmaceuticals Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE™ Molecule April 8, 2022
Longwood Fund Announces Longwood Healthcare Leaders, a Web Conference for Industry Leaders, on May 4-5, 2022 March 30, 2022
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment March 17, 2022
Green Journal Publishes Study Showing leva “Significantly Improved” Symptoms of Urinary Incontinence in Women versus Kegel Exercises Alone March 14, 2022
